Cervical Cancer Diagnostic Market in USA & Canada 2018-2024: Patients by Test Type (Pap Smear, HPV DNA) in North America - ResearchAndMarkets.com

DUBLIN--()--The "USA & Canada Cervical Cancer Diagnostic Market, Patients by Test Type (Pap Smear, HPV DNA), in North America" report has been added to ResearchAndMarkets.com's offering.

Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences.

North America Cervical Cancer Screening Market is projected to reach US$ 100 Million by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human papillomavirus (HPV) virus.

Increasing cervical cancer prevalence rate is one of the key factors that drive the cervical cancer screening market. Rapidly increasing female population, growing incidence of HPV infections and increasing awareness about cervical cancer screening programs are also expected to drive the cervical cancer screening market in the near future.

By Test Types - Pap smear Screening Tests are gaining popularity in North America

The report studies the market and population of the following cervical cancer screening tests: Pap smear Tests and HPV DNA Tests. Pap smear and HPV DNA tests are more popular with the developed countries such as the United States.

By Country - United State has a bright future in Cervical Cancer Screening Market in the near future

The report studies the market/screened a population of two big North American countries (United State and Canada) which provides a complete country-wise analysis of North America Cervical Cancer Screening Market, Population, and Mortality.

Key Topics Covered

1. Executive Summary

2. North America Cervical Cancer Test (Screening) Analysis

3. Market & Population Share - By Countries

4. United States - Cervical Cancer Test Analysis

5. Canada - Cervical Cancer Test Analysis

6. Growth Drivers

7. Challenges

For more information about this report visit https://www.researchandmarkets.com/research/r5f67x/cervical_cancer?w=4

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics